As the knowledge of the microbiome continues to deepen, we become more committed to working with innovative researchers and industry leaders to build events that focus on applied science and translate cutting edge microbiome R&D into safe, effective and commercially viable products across a number of industry-specific verticals.
Positioned in the heart of pharmaceutical, agricultural and nutrition R&D, these events will help accelerate discovery, development and delivery of microbiome-based products that benefit human health and unlock the secret to global challenges. For each specific industry where the microbiome will have a real impact, we’re building an exclusive Microbiome Movement for you to maximise the opportunity.
For live updates on what’s happening at Microbiome Movement, follow us on Twitter @MicrobiomeDaily
Microbiome Drug Development Summit Boston is the flagship event of the Microbiome Movement prepared for industry leaders to help accelerate the precise translation of microbiome R&D from disease causation into safe, effective and commercially scalable therapeutics..
Situated at the heart of therapeutic R&D, the Microbiome Drug Development Summit is focused on helping large pharma, biotech and academic institutions accelerate the discovery, clinical development of safe, effective and commercially scalable microbiome therapeutics across a broad range of disease indications.
Microbiome AgBioTech Summit is the only end-to-end meeting exclusively designed for industry and researchers to help discover, deliver and commercialize microbial research into products that increase yield, enhance productivity and maximize return.
Microbiome Human Nutrition Summit is a dedicated conference to help prebiotic, probiotic, food and pharmaceutical manufacturers commercialize the microbiome into next-generation food and nutrition products that are proven to improve human health.
Microbiome Gut-Brain Axis Summit is dedicated to help large pharma, biotech, and academic researchers unlock the potential of the gut-brain axis in demonstrating disease causation and translating these findings into safe and effective therapeutic candidates.